Abstract

A growing number of pharmacological and device-based therapies are available to improve well-being and prognosis for patients with heart failure. The increasing complexity of the treatment algorithm also makes implementation of optimal therapy challenging for the healthcare system and the physician. Recent years have seen increasing implementation of heart failure therapies in Sweden, but there is still meaningful room for improvement. Key factors to enable continued progress include knowledge dissemination and clinical decision-support systems that might include alerts and/or »nudging« in the electronic health record system, increased resources to improve the access to heart failure nurses and specialist cardiology care, heart failure registries, and digital/registry-based screening for missed diagnoses or treatment of heart failure.

Affiliated Institutions

Related Publications

Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long‐Term Registry

Aims To evaluate how recommendations of European guidelines regarding pharmacological and non‐pharmacological treatments for heart failure (HF) are adopted in clinical practice....

2013 European Journal of Heart Failure 643 citations

Publication Info

Year
2025
Type
article
Volume
122
Citations
0
Access
Closed

External Links

Citation Metrics

0
OpenAlex

Cite This

Felix Lindberg, Camilla Hage, Lena Olsson et al. (2025). [Treatment of heart failure in Sweden: progress but not there yet].. PubMed , 122 .